NCT05749627View on ClinicalTrials.gov

Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Advanced Malignant Solid Tumors
Interventions
DRUG

Neoantigen peptide vaccine

Personalized tumor neoantigen peptide vaccine

DRUG

Neoantigen-based DC immune preparation

Personalized tumor neoantigen DC therapeutic immune preparation

Trial Locations (1)

330006

RECRUITING

First Affiliated Hospital of Nanchang University, Nanchang

All Listed Sponsors
collaborator

Shanghai Dengding BioAI Co.

UNKNOWN

lead

The First Affiliated Hospital of Nanchang University

OTHER